Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.5 Certificate of Incorporation of Morphogenesis, Inc., As Currently In Effect
- 3.6 Bylaws of Morphogenesis, Inc., As Currently In Effect
- 4.9 Form of Morphogenesis, Inc. Common Stock Purchase Warrant Issued In Series a Preferred Stock Offering
- 4.10 Form of Morphogenesis, Inc. Common Stock Purchase Warrant, Dated June 1, 2019, Issued for Advisory Services
- 4.11 Form of Morphogenesis, Inc. Common Stock Purchase Warrant Issued In Series A-1 Preferred Offering
- 4.12 Form of Morphogenesis, Inc. Common Stock Purchase Warrant Issued In Note Conversion Transaction
- 4.13 Form of Morphogenesis, Inc. Common Stock Purchase Warrant Issued In Series B Preferred Stock Offering
- 10.21 Amended and Restated Equity Plan of Morphogenesis, Inc
- 10.22 Form of Option Agreement Under the Amended and Restated Equity Plan of Morphogenesis, Inc
- 10.23 First Amended and Restated Employment Agreement, Dated May 22, 2023, Between Morphogenesis, Inc. and Dan Dearborn
- 10.24 First Amended and Restated Employment Agreement, Dated May 22, 2023, Between Morphogenesis, Inc. and James Bianco, M.D
- 10.25 Consulting Agreement, Dated July 1, 2021, Between Morphogenesis, Inc. and Wyaldkatz, LLC
- 10.26 Amendment, Dated February 14, 2022, to Consulting Agreement, Dated July 1, 2021, Between Morphogenesis, Inc. and Wyaldkatz, LLC
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Cohbar, Inc
- 23.2 Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm of Morphogenesis, Inc
- 99.3 Consent of James Manuso to Serve As a Director of Cohbar, Inc., to Be Renamed Tuhura Biosciences, Inc.
- 99.4 Consent of James Bianco, M.D. to Serve As a Director of Cohbar, Inc., to Be Renamed Tuhura Biosciences, Inc.
- 99.5 Consent of Alan List, M.D. to Serve As a Director of Cohbar, Inc., to Be Renamed Tuhura Biosciences, Inc.
- 99.6 Consent of George NG to Serve As a Director of Cohbar, Inc., to Be Renamed Tuhura Biosciences, Inc.
- 99.7 Consent of Ladenburg Thalmann & Co. Inc.
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 13 Sep 23 EFFECT Notice of effectiveness
- 12 Sep 23 424B3 Prospectus supplement
- 12 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
30 Jun 23 S-4 Registration of securities issued in business combination transactions
CWBR similar filings
- 12 Sep 23 Registration of securities issued in business combination transactions (amended)
- 29 Aug 23 Registration of securities issued in business combination transactions (amended)
- 10 Aug 23 Registration of securities issued in business combination transactions (amended)
- 30 Jun 23 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of CohBar, Inc. on Form S-4 of our report dated March 9, 2023, with respect to our audits of the financial statements of CohBar, Inc. as of December 31, 2022 and 2021, and for the years ended December 31, 2022 and 2021, which report appears in the proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Proxy Statement/Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
June 30, 2023